Cargando…
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first‐in‐class calciu...
Autores principales: | Pölzl, Gerhard, Allipour Birgani, Shadab, Comín‐Colet, Josep, Delgado, Juan F., Fedele, Francesco, García‐Gonzáles, Martín Jesús, Gustafsson, Finn, Masip, Josep, Papp, Zoltán, Störk, Stefan, Ulmer, Hanno, Vrtovec, Bojan, Wikström, Gerhard, Altenberger, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351894/ https://www.ncbi.nlm.nih.gov/pubmed/30378288 http://dx.doi.org/10.1002/ehf2.12366 |
Ejemplares similares
-
Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018) -
Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey
por: Howlett, Jonathan, et al.
Publicado: (2017) -
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)